Φλουοξετίνη (Greek Wikipedia)

Analysis of information sources in references of the Wikipedia article "Φλουοξετίνη" in Greek language version.

refsWebsite

Global rank Greek rank

60nih.gov

4^th place

44doi.org

2^nd place

3^rd place

25web.archive.org

1^st place

8archive.org

6^th place

5^th place

6fda.gov

447^th place

368^th place

4drugs.com

399^th place

130^th place

4worldcat.org

5^th place

8^th place

3books.google.com

3^rd place

6^th place

2clincalc.com

3,912^th place

594^th place

2mhra.gov.uk

low place

2guidetopharmacology.org

low place

1tga.gov.au

3,984^th place

2,133^rd place

1harvard.edu

18^th place

57^th place

1nice.org.uk

3,258^th place

2,509^th place

1wfsbp.org

low place

1medicinescomplete.com

low place

5,144^th place

1researchgate.net

120^th place

213^th place

1mediafire.com

4,910^th place

low place

1rarebirdinc.com

low place

1crediblemeds.org

low place

1springer.de

low place

8,812^th place

1rxlist.com

7,927^th place

3,123^rd place

1ncl.ac.uk

4,362^nd place

3,663^rd place

1indystar.com

1,646^th place

5,169^th place

1fortune.com

433^rd place

801^st place

archive.org

Myers, Richard L. (2007). The 100 most important chemical compounds: a reference guide (1st έκδοση). Westport, Conn.: Greenwood Press. σελ. 128. ISBN 978-0-313-33758-1.
The Maudsley prescribing guidelines in psychiatry. West Sussex: Wiley-Blackwell. 2012. ISBN 978-0-470-97948-8.
«Clinical inquiry: How do antidepressants affect sexual function?». The Journal of Family Practice 62 (11): 660–1. November 2013. PMID 24288712. https://archive.org/details/sim_journal-of-family-practice_2013-11_62_11/page/660.
«Antidepressant Discontinuation Syndrome». American Family Physician 74 (3): 449–56. 1 August 2006. PMID 16913164. https://archive.org/details/sim_american-family-physician_2006-08-01_74_3/page/449.
«Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex». Psychopharmacology 160 (4): 353–61. April 2002. doi:10.1007/s00213-001-0986-x. PMID 11919662. https://archive.org/details/sim_psychopharmacology_2002-04_160_4/page/353.
«Fluoxetine increases GABA(A) receptor activity through a novel modulatory site». The Journal of Pharmacology and Experimental Therapeutics 304 (3): 978–84. March 2003. doi:10.1124/jpet.102.044834. PMID 12604672. https://archive.org/details/sim_journal-of-pharmacology-and-experimental-therapeutics_2003-03_304_3/page/978.
«Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication». Life Sciences 57 (5): 411–41. 1995. doi:10.1016/0024-3205(95)00209-O. PMID 7623609. https://archive.org/details/sim_life-sciences_1995_57_5/page/411.
Breggin, Peter R.· Breggin, Ginger Ross (1995). Talking Back to Prozac. Macmillan Publishers. σελίδες 1–2. ISBN 978-0-312-95606-6.

books.google.com

Hubbard JR, Martin PR (2001). Substance Abuse in the Mentally and Physically Disabled (στα Αγγλικά). CRC Press. σελ. 26. ISBN 9780824744977.
Hagerman, Randi Jenssen (16 Σεπτεμβρίου 1999). Neurodevelopmental Disorders: Diagnosis and Treatment. Oxford University Press. ISBN 978-0-19-512314-2. Dech and Budow (1991) were among the first to report the anecdotal use of fluoxetine in a case of PWS to control behavior problems, appetite, and trichotillomania.
Janicak, Philip G.· Marder, Stephen R. (26 Δεκεμβρίου 2011). Principles and Practice of Psychopharmacotherapy (στα Αγγλικά). Lippincott Williams & Wilkins. ISBN 978-1-4511-7877-7. A 2-week interval is adequate for all of these drugs, with the exception of fluoxetine. Because of the extended half-life of norfluoxetine, a minimum of 5 weeks should lapse between stopping fluoxetine (20mg/day) and starting an MAOI. With higher daily doses, the interval should be longer.

clincalc.com

«The Top 300 of 2020». ClinCalc. Ανακτήθηκε στις 11 Απριλίου 2020.
«Fluoxetine Hydrochloride - Drug Usage Statistics». ClinCalc. 23 Δεκεμβρίου 2019. Αρχειοθετήθηκε από το πρωτότυπο στις 11 Απριλίου 2020. Ανακτήθηκε στις 11 Απριλίου 2020.

crediblemeds.org

«CredibleMeds :: Quicksearch». crediblemeds.org. Ανακτήθηκε στις 2 Σεπτεμβρίου 2019.

doi.org

dx.doi.org

«Clinical pharmacokinetics of fluoxetine». Clinical Pharmacokinetics 26 (3): 201–14. March 1994. doi:10.2165/00003088-199426030-00004. PMID 8194283.
«Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)». The Cochrane Database of Systematic Reviews 8 (8): CD004677. August 2013. doi:10.1002/14651858.CD004677.pub3. PMID 23959778.
«The status of pharmacotherapy for autism spectrum disorders». Expert Opinion on Pharmacotherapy 8 (11): 1579–603. August 2007. doi:10.1517/14656566.8.11.1579. PMID 17685878.
«Pharmacotherapy to control behavioral symptoms in children with autism». Expert Opinion on Pharmacotherapy 13 (11): 1615–29. August 2012. doi:10.1517/14656566.2012.674110. PMID 22550944.
«Pharmacotherapy of autism spectrum disorders». Brain & Development 35 (2): 119–27. February 2013. doi:10.1016/j.braindev.2012.03.015. PMID 22541665.
«Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis». Lancet 391 (10128): 1357–1366. April 2018. doi:10.1016/S0140-6736(17)32802-7. PMID 29477251.
«Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration». PLOS Medicine 5 (2): e45. February 2008. doi:10.1371/journal.pmed.0050045. PMID 18303940.
«Antidepressant drug effects and depression severity: a patient-level meta-analysis». JAMA 303 (1): 47–53. January 2010. doi:10.1001/jama.2009.1943. PMID 20051569.
«Benefits from antidepressants: synthesis of 6-week patient-level outcomes from double-blind placebo-controlled randomized trials of fluoxetine and venlafaxine». Archives of General Psychiatry 69 (6): 572–9. June 2012. doi:10.1001/archgenpsychiatry.2011.2044. PMID 22393205.
«Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential Analysis». BMC Psychiatry 17 (1): 58. February 2017. doi:10.1186/s12888-016-1173-2. PMID 28178949.
«Practice parameter for the assessment and treatment of children and adolescents with obsessive-compulsive disorder». Journal of the American Academy of Child and Adolescent Psychiatry 51 (1): 98–113. January 2012. doi:10.1016/j.jaac.2011.09.019. PMID 22176943.
«World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of eating disorders». The World Journal of Biological Psychiatry 12 (6): 400–43. September 2011. doi:10.3109/15622975.2011.602720. ISSN 1814-1412. PMID 21961502. Αρχειοθετήθηκε από το πρωτότυπο στις 1 August 2014. https://web.archive.org/web/20140801032832/http://www.wfsbp.org/fileadmin/user_upload/Treatment_Guidelines/Aigner_WFSBP_guidelines_eating_disorder_World_J_Biol_Psychia_11.pdf.
«Pharmacotherapy in depressed children and adolescents». The World Journal of Biological Psychiatry 12 Suppl 1 (Suppl 1): 11–5. September 2011. doi:10.3109/15622975.2011.600295. PMID 21905988.
«Should the use of selective serotonin reuptake inhibitors in child and adolescent depression be banned?». Psychotherapy and Psychosomatics 76 (1): 5–14. 2007. doi:10.1159/000096360. PMID 17170559.
«Fluoxetine during pregnancy: impact on fetal development». Reproduction, Fertility, and Development 17 (6): 641–50. March 2005. doi:10.1071/RD05030. PMID 16263070.
«The use of antidepressants in pregnant and breastfeeding women: a review of recent studies». Journal of Human Lactation 26 (2): 187–95. May 2010. doi:10.1177/0890334409342071. PMID 19652194.
«Rapid infusion of sodium bicarbonate and albumin into high-risk premature infants soon after birth: a controlled, prospective trial». American Journal of Obstetrics and Gynecology 124 (3): 263–7. February 1976. doi:10.1016/0002-9378(76)90154-x. PMID 2013.
«Persistent sexual dysfunction after discontinuation of selective serotonin reuptake inhibitors». The Journal of Sexual Medicine 5 (1): 227–33. January 2008. doi:10.1111/j.1743-6109.2007.00630.x. PMID 18173768.
«Persistent sexual side effects after SSRI discontinuation». Psychotherapy and Psychosomatics 75 (3): 187–8. 2006. doi:10.1159/000091777. PMID 16636635. https://www.researchgate.net/publication/7143554. PDF also here (proof version)
«A review of the management of antidepressant discontinuation symptoms». Therapeutic Advances in Psychopharmacology 5 (6): 357–68. December 2015. doi:10.1177/2045125315612334. PMID 26834969.
«Recognition and management of antidepressant discontinuation syndrome». J Psychiatry Neurosci 42 (4): 7–8. June 2017. doi:10.1503/jpn.170022. PMID 28639936.
«Antidepressant discontinuation syndrome». Canadian Medical Association Journal 189 (21): 747. 29 May 2017. doi:10.1503/cmaj.160991. PMID 28554948.
«The flawed basis for FDA post-marketing safety decisions: the example of anti-depressants and children». Neuropsychopharmacology 31 (4): 689–99. April 2006. doi:10.1038/sj.npp.1300996. PMID 16395296.
«Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review». BMJ 330 (7488): 385. February 2005. doi:10.1136/bmj.330.7488.385. PMID 15718537.
Cubeddu, Luigi X. (2016). «Drug-induced Inhibition and Trafficking Disruption of ion Channels: Pathogenesis of QT Abnormalities and Drug-induced Fatal Arrhythmias». Current Cardiology Reviews 12 (2): 141–154. doi:10.2174/1573403X12666160301120217. ISSN 1875-6557. PMID 26926294.
Tisdale, James E. (May 2016). «Drug-induced QT interval prolongation and torsades de pointes: Role of the pharmacist in risk assessment, prevention and management». Canadian Pharmacists Journal 149 (3): 139–152. doi:10.1177/1715163516641136. ISSN 1715-1635. PMID 27212965.
«Fluoxetine increases norepinephrine release in rat hypothalamus as measured by tissue levels of MHPG-SO4 and microdialysis in conscious rats». Journal of Neural Transmission 104 (8–9): 953–66. 1997. doi:10.1007/BF01285563. PMID 9451727.
«Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex». Psychopharmacology 160 (4): 353–61. April 2002. doi:10.1007/s00213-001-0986-x. PMID 11919662. https://archive.org/details/sim_psychopharmacology_2002-04_160_4/page/353.
«R-fluoxetine increases extracellular DA, NE, as well as 5-HT in rat prefrontal cortex and hypothalamus: an in vivo microdialysis and receptor binding study». Neuropsychopharmacology 27 (6): 949–59. December 2002. doi:10.1016/S0893-133X(02)00377-9. PMID 12464452.
«SSRIs act as selective brain steroidogenic stimulants (SBSSs) at low doses that are inactive on 5-HT reuptake». Current Opinion in Pharmacology 9 (1): 24–30. February 2009. doi:10.1016/j.coph.2008.12.006. PMID 19157982.
«alpha(2)-Adrenoceptors mediate the acute inhibitory effect of fluoxetine on locus coeruleus noradrenergic neurons». Neuropharmacology 56 (6–7): 1068–73. 2009. doi:10.1016/j.neuropharm.2009.03.004. PMID 19298831.
«Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2c receptor». Psychopharmacology 126 (3): 234–40. August 1996. doi:10.1007/BF02246453. PMID 8876023. http://link.springer.de/link/service/journals/00213/bibs/6126003/61260234.htm.
«Neuroactive steroids and stress axis regulation: Pregnancy and beyond». The Journal of Steroid Biochemistry and Molecular Biology 160: 160–8. June 2016. doi:10.1016/j.jsbmb.2015.08.003. PMID 26259885.
«Fluoxetine increases GABA(A) receptor activity through a novel modulatory site». The Journal of Pharmacology and Experimental Therapeutics 304 (3): 978–84. March 2003. doi:10.1124/jpet.102.044834. PMID 12604672. https://archive.org/details/sim_journal-of-pharmacology-and-experimental-therapeutics_2003-03_304_3/page/978.
«Interactions of selective serotonin reuptake inhibitors with subtypes of sigma receptors in rat brain». European Journal of Pharmacology 307 (1): 117–9. June 1996. doi:10.1016/0014-2999(96)00254-3. PMID 8831113.
«Sigma-1 receptors and selective serotonin reuptake inhibitors: clinical implications of their relationship». Central Nervous System Agents in Medicinal Chemistry 9 (3): 197–204. September 2009. doi:10.2174/1871524910909030197. PMID 20021354.
«Fluoxetine metabolism and pharmacological interactions: the role of cytochrome p450». Current Drug Metabolism 7 (2): 127–33. February 2006. doi:10.2174/138920006775541561. PMID 16472103.
«Pharmacokinetics of selective serotonin reuptake inhibitors». Pharmacology & Therapeutics 85 (1): 11–28. January 2000. doi:10.1016/S0163-7258(99)00048-0. PMID 10674711.
«Weekly dosing of fluoxetine for the continuation phase of treatment of major depression: results of a placebo-controlled, randomized clinical trial». Journal of Clinical Psychopharmacology 20 (4): 423–7. August 2000. doi:10.1097/00004714-200008000-00006. PMID 10917403.
«Augmentation of fluoxetine's antidepressant action by pindolol: analysis of clinical, pharmacokinetic, and methodologic factors». Journal of Clinical Psychopharmacology 21 (1): 36–45. February 2001. doi:10.1097/00004714-200102000-00008. PMID 11199945.
«Fluoxetine and norfluoxetine plasma concentrations during relapse-prevention treatment». Journal of Affective Disorders 68 (2–3): 243–9. April 2002. doi:10.1016/S0165-0327(00)00333-5. PMID 12063152.
«A comparison of brain and serum pharmacokinetics of R-fluoxetine and racemic fluoxetine: A 19-F MRS study». Neuropsychopharmacology 30 (8): 1576–83. August 2005. doi:10.1038/sj.npp.1300749. PMID 15886723.
«Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication». Life Sciences 57 (5): 411–41. 1995. doi:10.1016/0024-3205(95)00209-O. PMID 7623609. https://archive.org/details/sim_life-sciences_1995_57_5/page/411.
«A selective inhibitor of serotonin uptake: Lilly 110140, 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine». Life Sciences 15 (3): 471–9. August 1974. doi:10.1016/0024-3205(74)90345-2. PMID 4549929.

drugs.com

«Fluoxetine Hydrochloride». The American Society of Health-System Pharmacists. Αρχειοθετήθηκε από το πρωτότυπο στις 8 Δεκεμβρίου 2015. Ανακτήθηκε στις 2 Δεκεμβρίου 2015.
«Fluoxetine Pregnancy and Breastfeeding Warnings». Αρχειοθετήθηκε από το πρωτότυπο στις 31 Αυγούστου 2017. Ανακτήθηκε στις 2 Δεκεμβρίου 2015.
«Fluoxetine Hydrochloride». The American Society of Health-System Pharmacists. Αρχειοθετήθηκε από το πρωτότυπο στις 11 Απριλίου 2011. Ανακτήθηκε στις 3 Απριλίου 2011.
«Fluoxetine and ibuprofen Drug Interactions». Drugs.com. Αρχειοθετήθηκε από το πρωτότυπο στις 31 Αυγούστου 2017. Ανακτήθηκε στις 3 Μαρτίου 2017.

fda.gov

«Antidepressants and Suicidality in Adults: Statistical Evaluation. (Presentation at Psychopharmacologic Drugs Advisory Committee; December 13, 2006)». Αρχειοθετήθηκε από το πρωτότυπο στις 27 Σεπτεμβρίου 2007. Ανακτήθηκε στις 13 Μαΐου 2007.
«Clinical Review: Relationship Between Antidepressant Drugs and Suicidality in Adults» (PDF). Overview for December 13 Meeting of Psychopharmacologic Drugs Advisory Committee (PDAC). FDA. 17 Νοεμβρίου 2006. σελίδες 11–74. Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 16 Μαρτίου 2007. Ανακτήθηκε στις 22 Σεπτεμβρίου 2007.
«Statistical Evaluation of Suicidality in Adults Treated with Antidepressants» (PDF). Overview for December 13 Meeting of Psychopharmacologic Drugs Advisory Committee (PDAC). FDA. 17 Νοεμβρίου 2006. σελίδες 75–140. Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 16 Μαρτίου 2007. Ανακτήθηκε στις 22 Σεπτεμβρίου 2007.
Hammad, Tarek A. (13 Σεπτεμβρίου 2004). «Results of the Analysis of Suicidality in Pediatric Trials of Newer Antidepressants». Presentation at the Meeting of Psychopharmacologic Drugs Advisory Committee and the Pediatric Advisory Committee on September 13, 2004. FDA. Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 28 Φεβρουαρίου 2008. Pages 25, 28. Retrieved 6 January 2008.

accessdata.fda.gov

«Prozac Label» (PDF). FDA. 2014. Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 4 Μαρτίου 2016. Ανακτήθηκε στις 5 Απριλίου 2016.
«Electronic Orange Book». Food and Drug Administration. Απριλίου 2007. Αρχειοθετήθηκε από το πρωτότυπο στις 20 Αυγούστου 2007. Ανακτήθηκε στις 24 Μαΐου 2007.

fortune.com

archive.fortune.com

Simons, John (28 Ιουνίου 2004). «Lilly Goes Off Prozac The drugmaker bounced back from the loss of its blockbuster, but the recovery had costs». Fortune Magazine. Αρχειοθετήθηκε από το πρωτότυπο στις 26 Απριλίου 2016. Ανακτήθηκε στις 26 Σεπτεμβρίου 2020.

guidetopharmacology.org

«Fluoxetine». IUPHAR Guide to Pharmacology. IUPHAR. Αρχειοθετήθηκε από το πρωτότυπο στις 10 Νοεμβρίου 2014. Ανακτήθηκε στις 10 Νοεμβρίου 2014.
«Calcium activated chloride channel». IUPHAR Guide to Pharmacology. IUPHAR. Αρχειοθετήθηκε από το πρωτότυπο στις 10 Νοεμβρίου 2014. Ανακτήθηκε στις 10 Νοεμβρίου 2014.

harvard.edu

health.harvard.edu

Publishing, Harvard Health. «Treating social anxiety disorder». Harvard Health. Αρχειοθετήθηκε από το πρωτότυπο στις 23 Σεπτεμβρίου 2020. Ανακτήθηκε στις 15 Μαΐου 2019.

indystar.com

www2.indystar.com

Swiatek, Jeff (2 August 2001). «Prozac's profitable run coming to an end for Lilly». The Indianapolis Star. Αρχειοθετήθηκε από το πρωτότυπο στις 18 August 2007. https://web.archive.org/web/20070818163109/http://www2.indystar.com/library/factfiles/business/companies/lilly/stories/2001_0802.html.

mediafire.com

«Persistent sexual side effects after SSRI discontinuation». Psychotherapy and Psychosomatics 75 (3): 187–8. 2006. doi:10.1159/000091777. PMID 16636635. https://www.researchgate.net/publication/7143554. PDF also here (proof version)

medicinescomplete.com

Brayfield, A, επιμ. (13 Αυγούστου 2013). Fluoxetine Hydrochloride. London, UK: Pharmaceutical Press. Ανακτήθηκε στις 24 Νοεμβρίου 2013. (απαιτείται συνδρομή)

mhra.gov.uk

«Fluoxetine in pregnancy: slight risk of heart defects in unborn child» (PDF). MHRA. Medicines and Healthcare products Regulatory Agency. 10 Σεπτεμβρίου 2011. Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 2 Δεκεμβρίου 2013. Ανακτήθηκε στις 23 Νοεμβρίου 2013.
Committee on Safety of Medicines Expert Working Group (Δεκεμβρίου 2004). «Report on The Safety of Selective Serotonin Reuptake Inhibitor Antidepressants» (PDF). MHRA. Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 28 Φεβρουαρίου 2008. Ανακτήθηκε στις 25 Σεπτεμβρίου 2007.

ncl.ac.uk

«Drug Treatments in Psychiatry: Antidepressants». Newcastle University School of Neurology, Neurobiology and Psychiatry. 2005. Αρχειοθετήθηκε από το πρωτότυπο στις 17 Απριλίου 2007. Ανακτήθηκε στις 14 Απριλίου 2007.

nice.org.uk

guidance.nice.org.uk

«CG90 Depression in adults: full guidance». National Institute for Health and Care Excellence. Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 9 Ιανουαρίου 2014.

nih.gov

ncbi.nlm.nih.gov

«Clinical pharmacokinetics of fluoxetine». Clinical Pharmacokinetics 26 (3): 201–14. March 1994. doi:10.2165/00003088-199426030-00004. PMID 8194283.
«Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)». The Cochrane Database of Systematic Reviews 8 (8): CD004677. August 2013. doi:10.1002/14651858.CD004677.pub3. PMID 23959778.
«The status of pharmacotherapy for autism spectrum disorders». Expert Opinion on Pharmacotherapy 8 (11): 1579–603. August 2007. doi:10.1517/14656566.8.11.1579. PMID 17685878.
«Pharmacotherapy to control behavioral symptoms in children with autism». Expert Opinion on Pharmacotherapy 13 (11): 1615–29. August 2012. doi:10.1517/14656566.2012.674110. PMID 22550944.
«Pharmacotherapy of autism spectrum disorders». Brain & Development 35 (2): 119–27. February 2013. doi:10.1016/j.braindev.2012.03.015. PMID 22541665.
«Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis». Lancet 391 (10128): 1357–1366. April 2018. doi:10.1016/S0140-6736(17)32802-7. PMID 29477251.
«Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration». PLOS Medicine 5 (2): e45. February 2008. doi:10.1371/journal.pmed.0050045. PMID 18303940.
«Antidepressant drug effects and depression severity: a patient-level meta-analysis». JAMA 303 (1): 47–53. January 2010. doi:10.1001/jama.2009.1943. PMID 20051569.
«Benefits from antidepressants: synthesis of 6-week patient-level outcomes from double-blind placebo-controlled randomized trials of fluoxetine and venlafaxine». Archives of General Psychiatry 69 (6): 572–9. June 2012. doi:10.1001/archgenpsychiatry.2011.2044. PMID 22393205.
«Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential Analysis». BMC Psychiatry 17 (1): 58. February 2017. doi:10.1186/s12888-016-1173-2. PMID 28178949.
«Practice parameter for the assessment and treatment of children and adolescents with obsessive-compulsive disorder». Journal of the American Academy of Child and Adolescent Psychiatry 51 (1): 98–113. January 2012. doi:10.1016/j.jaac.2011.09.019. PMID 22176943.
«World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of eating disorders». The World Journal of Biological Psychiatry 12 (6): 400–43. September 2011. doi:10.3109/15622975.2011.602720. ISSN 1814-1412. PMID 21961502. Αρχειοθετήθηκε από το πρωτότυπο στις 1 August 2014. https://web.archive.org/web/20140801032832/http://www.wfsbp.org/fileadmin/user_upload/Treatment_Guidelines/Aigner_WFSBP_guidelines_eating_disorder_World_J_Biol_Psychia_11.pdf.
«Pharmacotherapy in depressed children and adolescents». The World Journal of Biological Psychiatry 12 Suppl 1 (Suppl 1): 11–5. September 2011. doi:10.3109/15622975.2011.600295. PMID 21905988.
«Should the use of selective serotonin reuptake inhibitors in child and adolescent depression be banned?». Psychotherapy and Psychosomatics 76 (1): 5–14. 2007. doi:10.1159/000096360. PMID 17170559.
«Fluoxetine during pregnancy: impact on fetal development». Reproduction, Fertility, and Development 17 (6): 641–50. March 2005. doi:10.1071/RD05030. PMID 16263070.
«The use of antidepressants in pregnant and breastfeeding women: a review of recent studies». Journal of Human Lactation 26 (2): 187–95. May 2010. doi:10.1177/0890334409342071. PMID 19652194.
«Rapid infusion of sodium bicarbonate and albumin into high-risk premature infants soon after birth: a controlled, prospective trial». American Journal of Obstetrics and Gynecology 124 (3): 263–7. February 1976. doi:10.1016/0002-9378(76)90154-x. PMID 2013.
«Clinical inquiry: How do antidepressants affect sexual function?». The Journal of Family Practice 62 (11): 660–1. November 2013. PMID 24288712. https://archive.org/details/sim_journal-of-family-practice_2013-11_62_11/page/660.
«Persistent sexual dysfunction after discontinuation of selective serotonin reuptake inhibitors». The Journal of Sexual Medicine 5 (1): 227–33. January 2008. doi:10.1111/j.1743-6109.2007.00630.x. PMID 18173768.
«Persistent sexual side effects after SSRI discontinuation». Psychotherapy and Psychosomatics 75 (3): 187–8. 2006. doi:10.1159/000091777. PMID 16636635. https://www.researchgate.net/publication/7143554. PDF also here (proof version)
«A review of the management of antidepressant discontinuation symptoms». Therapeutic Advances in Psychopharmacology 5 (6): 357–68. December 2015. doi:10.1177/2045125315612334. PMID 26834969.
«Recognition and management of antidepressant discontinuation syndrome». J Psychiatry Neurosci 42 (4): 7–8. June 2017. doi:10.1503/jpn.170022. PMID 28639936.
«Antidepressant Discontinuation Syndrome». American Family Physician 74 (3): 449–56. 1 August 2006. PMID 16913164. https://archive.org/details/sim_american-family-physician_2006-08-01_74_3/page/449.
«Antidepressant discontinuation syndrome». Canadian Medical Association Journal 189 (21): 747. 29 May 2017. doi:10.1503/cmaj.160991. PMID 28554948.
«The flawed basis for FDA post-marketing safety decisions: the example of anti-depressants and children». Neuropsychopharmacology 31 (4): 689–99. April 2006. doi:10.1038/sj.npp.1300996. PMID 16395296.
«Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review». BMJ 330 (7488): 385. February 2005. doi:10.1136/bmj.330.7488.385. PMID 15718537.
Cubeddu, Luigi X. (2016). «Drug-induced Inhibition and Trafficking Disruption of ion Channels: Pathogenesis of QT Abnormalities and Drug-induced Fatal Arrhythmias». Current Cardiology Reviews 12 (2): 141–154. doi:10.2174/1573403X12666160301120217. ISSN 1875-6557. PMID 26926294.
Tisdale, James E. (May 2016). «Drug-induced QT interval prolongation and torsades de pointes: Role of the pharmacist in risk assessment, prevention and management». Canadian Pharmacists Journal 149 (3): 139–152. doi:10.1177/1715163516641136. ISSN 1715-1635. PMID 27212965.
Gury, C.; Cousin, F. (September 1999). «[Pharmacokinetics of SSRI antidepressants: half-life and clinical applicability]». L'Encephale 25 (5): 470–476. ISSN 0013-7006. PMID 10598311.
«Fluoxetine increases norepinephrine release in rat hypothalamus as measured by tissue levels of MHPG-SO4 and microdialysis in conscious rats». Journal of Neural Transmission 104 (8–9): 953–66. 1997. doi:10.1007/BF01285563. PMID 9451727.
«Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex». Psychopharmacology 160 (4): 353–61. April 2002. doi:10.1007/s00213-001-0986-x. PMID 11919662. https://archive.org/details/sim_psychopharmacology_2002-04_160_4/page/353.
«R-fluoxetine increases extracellular DA, NE, as well as 5-HT in rat prefrontal cortex and hypothalamus: an in vivo microdialysis and receptor binding study». Neuropsychopharmacology 27 (6): 949–59. December 2002. doi:10.1016/S0893-133X(02)00377-9. PMID 12464452.
«SSRIs act as selective brain steroidogenic stimulants (SBSSs) at low doses that are inactive on 5-HT reuptake». Current Opinion in Pharmacology 9 (1): 24–30. February 2009. doi:10.1016/j.coph.2008.12.006. PMID 19157982.
«alpha(2)-Adrenoceptors mediate the acute inhibitory effect of fluoxetine on locus coeruleus noradrenergic neurons». Neuropharmacology 56 (6–7): 1068–73. 2009. doi:10.1016/j.neuropharm.2009.03.004. PMID 19298831.
«Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2c receptor». Psychopharmacology 126 (3): 234–40. August 1996. doi:10.1007/BF02246453. PMID 8876023. http://link.springer.de/link/service/journals/00213/bibs/6126003/61260234.htm.
«Neuroactive steroids and stress axis regulation: Pregnancy and beyond». The Journal of Steroid Biochemistry and Molecular Biology 160: 160–8. June 2016. doi:10.1016/j.jsbmb.2015.08.003. PMID 26259885.
«Fluoxetine increases GABA(A) receptor activity through a novel modulatory site». The Journal of Pharmacology and Experimental Therapeutics 304 (3): 978–84. March 2003. doi:10.1124/jpet.102.044834. PMID 12604672. https://archive.org/details/sim_journal-of-pharmacology-and-experimental-therapeutics_2003-03_304_3/page/978.
«Interactions of selective serotonin reuptake inhibitors with subtypes of sigma receptors in rat brain». European Journal of Pharmacology 307 (1): 117–9. June 1996. doi:10.1016/0014-2999(96)00254-3. PMID 8831113.
«Sigma-1 receptors and selective serotonin reuptake inhibitors: clinical implications of their relationship». Central Nervous System Agents in Medicinal Chemistry 9 (3): 197–204. September 2009. doi:10.2174/1871524910909030197. PMID 20021354.
«Fluoxetine metabolism and pharmacological interactions: the role of cytochrome p450». Current Drug Metabolism 7 (2): 127–33. February 2006. doi:10.2174/138920006775541561. PMID 16472103.
«Pharmacokinetics of selective serotonin reuptake inhibitors». Pharmacology & Therapeutics 85 (1): 11–28. January 2000. doi:10.1016/S0163-7258(99)00048-0. PMID 10674711.
«Weekly dosing of fluoxetine for the continuation phase of treatment of major depression: results of a placebo-controlled, randomized clinical trial». Journal of Clinical Psychopharmacology 20 (4): 423–7. August 2000. doi:10.1097/00004714-200008000-00006. PMID 10917403.
«Augmentation of fluoxetine's antidepressant action by pindolol: analysis of clinical, pharmacokinetic, and methodologic factors». Journal of Clinical Psychopharmacology 21 (1): 36–45. February 2001. doi:10.1097/00004714-200102000-00008. PMID 11199945.
«Fluoxetine and norfluoxetine plasma concentrations during relapse-prevention treatment». Journal of Affective Disorders 68 (2–3): 243–9. April 2002. doi:10.1016/S0165-0327(00)00333-5. PMID 12063152.
«A comparison of brain and serum pharmacokinetics of R-fluoxetine and racemic fluoxetine: A 19-F MRS study». Neuropsychopharmacology 30 (8): 1576–83. August 2005. doi:10.1038/sj.npp.1300749. PMID 15886723.
«Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication». Life Sciences 57 (5): 411–41. 1995. doi:10.1016/0024-3205(95)00209-O. PMID 7623609. https://archive.org/details/sim_life-sciences_1995_57_5/page/411.
«A selective inhibitor of serotonin uptake: Lilly 110140, 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine». Life Sciences 15 (3): 471–9. August 1974. doi:10.1016/0024-3205(74)90345-2. PMID 4549929.

pubmedcentral.nih.gov

«Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis». Lancet 391 (10128): 1357–1366. April 2018. doi:10.1016/S0140-6736(17)32802-7. PMID 29477251.
«Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration». PLOS Medicine 5 (2): e45. February 2008. doi:10.1371/journal.pmed.0050045. PMID 18303940.
«Antidepressant drug effects and depression severity: a patient-level meta-analysis». JAMA 303 (1): 47–53. January 2010. doi:10.1001/jama.2009.1943. PMID 20051569.
«Benefits from antidepressants: synthesis of 6-week patient-level outcomes from double-blind placebo-controlled randomized trials of fluoxetine and venlafaxine». Archives of General Psychiatry 69 (6): 572–9. June 2012. doi:10.1001/archgenpsychiatry.2011.2044. PMID 22393205.
«Selective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential Analysis». BMC Psychiatry 17 (1): 58. February 2017. doi:10.1186/s12888-016-1173-2. PMID 28178949.
«A review of the management of antidepressant discontinuation symptoms». Therapeutic Advances in Psychopharmacology 5 (6): 357–68. December 2015. doi:10.1177/2045125315612334. PMID 26834969.
«Recognition and management of antidepressant discontinuation syndrome». J Psychiatry Neurosci 42 (4): 7–8. June 2017. doi:10.1503/jpn.170022. PMID 28639936.
«Antidepressant discontinuation syndrome». Canadian Medical Association Journal 189 (21): 747. 29 May 2017. doi:10.1503/cmaj.160991. PMID 28554948.
«Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review». BMJ 330 (7488): 385. February 2005. doi:10.1136/bmj.330.7488.385. PMID 15718537.
Cubeddu, Luigi X. (2016). «Drug-induced Inhibition and Trafficking Disruption of ion Channels: Pathogenesis of QT Abnormalities and Drug-induced Fatal Arrhythmias». Current Cardiology Reviews 12 (2): 141–154. doi:10.2174/1573403X12666160301120217. ISSN 1875-6557. PMID 26926294.
Tisdale, James E. (May 2016). «Drug-induced QT interval prolongation and torsades de pointes: Role of the pharmacist in risk assessment, prevention and management». Canadian Pharmacists Journal 149 (3): 139–152. doi:10.1177/1715163516641136. ISSN 1715-1635. PMID 27212965.
«SSRIs act as selective brain steroidogenic stimulants (SBSSs) at low doses that are inactive on 5-HT reuptake». Current Opinion in Pharmacology 9 (1): 24–30. February 2009. doi:10.1016/j.coph.2008.12.006. PMID 19157982.

nimh.nih.gov

«NIMH•Eating Disorders». The National Institute of Mental Health. National Institute of Health. 2011. Αρχειοθετήθηκε από το πρωτότυπο στις 19 Αυγούστου 2011. Ανακτήθηκε στις 25 Νοεμβρίου 2013.

rarebirdinc.com

harvard.rarebirdinc.com

Publishing, Harvard Health. «Going off antidepressants». Harvard Health. Αρχειοθετήθηκε από το πρωτότυπο στις 26 Ιουνίου 2019. Ανακτήθηκε στις 26 Σεπτεμβρίου 2020.

researchgate.net

«Persistent sexual side effects after SSRI discontinuation». Psychotherapy and Psychosomatics 75 (3): 187–8. 2006. doi:10.1159/000091777. PMID 16636635. https://www.researchgate.net/publication/7143554. PDF also here (proof version)

rxlist.com

«Prozac Pharmacology, Pharmacokinetics, Studies, Metabolism». RxList.com. 2007. Αρχειοθετήθηκε από το πρωτότυπο στις 10 Απριλίου 2007. Ανακτήθηκε στις 14 Απριλίου 2007.

springer.de

link.springer.de

«Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2c receptor». Psychopharmacology 126 (3): 234–40. August 1996. doi:10.1007/BF02246453. PMID 8876023. http://link.springer.de/link/service/journals/00213/bibs/6126003/61260234.htm.

tga.gov.au

ebs.tga.gov.au

«PROZAC® Fluoxetine Hydrochloride» (PDF). TGA eBusiness Services. Eli Lilly Australia Pty. Limited. 9 Οκτωβρίου 2013. Αρχειοθετήθηκε από το πρωτότυπο στις 25 Απριλίου 2017. Ανακτήθηκε στις 23 Νοεμβρίου 2013.

web.archive.org

«Fluoxetine Hydrochloride». The American Society of Health-System Pharmacists. Αρχειοθετήθηκε από το πρωτότυπο στις 8 Δεκεμβρίου 2015. Ανακτήθηκε στις 2 Δεκεμβρίου 2015.
«Prozac Label» (PDF). FDA. 2014. Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 4 Μαρτίου 2016. Ανακτήθηκε στις 5 Απριλίου 2016.
«PROZAC® Fluoxetine Hydrochloride» (PDF). TGA eBusiness Services. Eli Lilly Australia Pty. Limited. 9 Οκτωβρίου 2013. Αρχειοθετήθηκε από το πρωτότυπο στις 25 Απριλίου 2017. Ανακτήθηκε στις 23 Νοεμβρίου 2013.
«Fluoxetine Pregnancy and Breastfeeding Warnings». Αρχειοθετήθηκε από το πρωτότυπο στις 31 Αυγούστου 2017. Ανακτήθηκε στις 2 Δεκεμβρίου 2015.
«Fluoxetine Hydrochloride - Drug Usage Statistics». ClinCalc. 23 Δεκεμβρίου 2019. Αρχειοθετήθηκε από το πρωτότυπο στις 11 Απριλίου 2020. Ανακτήθηκε στις 11 Απριλίου 2020.
«Fluoxetine Hydrochloride». The American Society of Health-System Pharmacists. Αρχειοθετήθηκε από το πρωτότυπο στις 11 Απριλίου 2011. Ανακτήθηκε στις 3 Απριλίου 2011.
«NIMH•Eating Disorders». The National Institute of Mental Health. National Institute of Health. 2011. Αρχειοθετήθηκε από το πρωτότυπο στις 19 Αυγούστου 2011. Ανακτήθηκε στις 25 Νοεμβρίου 2013.
Publishing, Harvard Health. «Treating social anxiety disorder». Harvard Health. Αρχειοθετήθηκε από το πρωτότυπο στις 23 Σεπτεμβρίου 2020. Ανακτήθηκε στις 15 Μαΐου 2019.
«CG90 Depression in adults: full guidance». National Institute for Health and Care Excellence. Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 9 Ιανουαρίου 2014.
«World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of eating disorders». The World Journal of Biological Psychiatry 12 (6): 400–43. September 2011. doi:10.3109/15622975.2011.602720. ISSN 1814-1412. PMID 21961502. Αρχειοθετήθηκε από το πρωτότυπο στις 1 August 2014. https://web.archive.org/web/20140801032832/http://www.wfsbp.org/fileadmin/user_upload/Treatment_Guidelines/Aigner_WFSBP_guidelines_eating_disorder_World_J_Biol_Psychia_11.pdf.
«Fluoxetine in pregnancy: slight risk of heart defects in unborn child» (PDF). MHRA. Medicines and Healthcare products Regulatory Agency. 10 Σεπτεμβρίου 2011. Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 2 Δεκεμβρίου 2013. Ανακτήθηκε στις 23 Νοεμβρίου 2013.
Publishing, Harvard Health. «Going off antidepressants». Harvard Health. Αρχειοθετήθηκε από το πρωτότυπο στις 26 Ιουνίου 2019. Ανακτήθηκε στις 26 Σεπτεμβρίου 2020.
«Antidepressants and Suicidality in Adults: Statistical Evaluation. (Presentation at Psychopharmacologic Drugs Advisory Committee; December 13, 2006)». Αρχειοθετήθηκε από το πρωτότυπο στις 27 Σεπτεμβρίου 2007. Ανακτήθηκε στις 13 Μαΐου 2007.
«Clinical Review: Relationship Between Antidepressant Drugs and Suicidality in Adults» (PDF). Overview for December 13 Meeting of Psychopharmacologic Drugs Advisory Committee (PDAC). FDA. 17 Νοεμβρίου 2006. σελίδες 11–74. Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 16 Μαρτίου 2007. Ανακτήθηκε στις 22 Σεπτεμβρίου 2007.
«Statistical Evaluation of Suicidality in Adults Treated with Antidepressants» (PDF). Overview for December 13 Meeting of Psychopharmacologic Drugs Advisory Committee (PDAC). FDA. 17 Νοεμβρίου 2006. σελίδες 75–140. Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 16 Μαρτίου 2007. Ανακτήθηκε στις 22 Σεπτεμβρίου 2007.
Hammad, Tarek A. (13 Σεπτεμβρίου 2004). «Results of the Analysis of Suicidality in Pediatric Trials of Newer Antidepressants». Presentation at the Meeting of Psychopharmacologic Drugs Advisory Committee and the Pediatric Advisory Committee on September 13, 2004. FDA. Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 28 Φεβρουαρίου 2008. Pages 25, 28. Retrieved 6 January 2008.
Committee on Safety of Medicines Expert Working Group (Δεκεμβρίου 2004). «Report on The Safety of Selective Serotonin Reuptake Inhibitor Antidepressants» (PDF). MHRA. Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 28 Φεβρουαρίου 2008. Ανακτήθηκε στις 25 Σεπτεμβρίου 2007.
«Fluoxetine and ibuprofen Drug Interactions». Drugs.com. Αρχειοθετήθηκε από το πρωτότυπο στις 31 Αυγούστου 2017. Ανακτήθηκε στις 3 Μαρτίου 2017.
«Fluoxetine». IUPHAR Guide to Pharmacology. IUPHAR. Αρχειοθετήθηκε από το πρωτότυπο στις 10 Νοεμβρίου 2014. Ανακτήθηκε στις 10 Νοεμβρίου 2014.
«Calcium activated chloride channel». IUPHAR Guide to Pharmacology. IUPHAR. Αρχειοθετήθηκε από το πρωτότυπο στις 10 Νοεμβρίου 2014. Ανακτήθηκε στις 10 Νοεμβρίου 2014.
«Prozac Pharmacology, Pharmacokinetics, Studies, Metabolism». RxList.com. 2007. Αρχειοθετήθηκε από το πρωτότυπο στις 10 Απριλίου 2007. Ανακτήθηκε στις 14 Απριλίου 2007.
«Drug Treatments in Psychiatry: Antidepressants». Newcastle University School of Neurology, Neurobiology and Psychiatry. 2005. Αρχειοθετήθηκε από το πρωτότυπο στις 17 Απριλίου 2007. Ανακτήθηκε στις 14 Απριλίου 2007.
Swiatek, Jeff (2 August 2001). «Prozac's profitable run coming to an end for Lilly». The Indianapolis Star. Αρχειοθετήθηκε από το πρωτότυπο στις 18 August 2007. https://web.archive.org/web/20070818163109/http://www2.indystar.com/library/factfiles/business/companies/lilly/stories/2001_0802.html.
«Electronic Orange Book». Food and Drug Administration. Απριλίου 2007. Αρχειοθετήθηκε από το πρωτότυπο στις 20 Αυγούστου 2007. Ανακτήθηκε στις 24 Μαΐου 2007.
Simons, John (28 Ιουνίου 2004). «Lilly Goes Off Prozac The drugmaker bounced back from the loss of its blockbuster, but the recovery had costs». Fortune Magazine. Αρχειοθετήθηκε από το πρωτότυπο στις 26 Απριλίου 2016. Ανακτήθηκε στις 26 Σεπτεμβρίου 2020.

wfsbp.org

«World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of eating disorders». The World Journal of Biological Psychiatry 12 (6): 400–43. September 2011. doi:10.3109/15622975.2011.602720. ISSN 1814-1412. PMID 21961502. Αρχειοθετήθηκε από το πρωτότυπο στις 1 August 2014. https://web.archive.org/web/20140801032832/http://www.wfsbp.org/fileadmin/user_upload/Treatment_Guidelines/Aigner_WFSBP_guidelines_eating_disorder_World_J_Biol_Psychia_11.pdf.

worldcat.org

«World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of eating disorders». The World Journal of Biological Psychiatry 12 (6): 400–43. September 2011. doi:10.3109/15622975.2011.602720. ISSN 1814-1412. PMID 21961502. Αρχειοθετήθηκε από το πρωτότυπο στις 1 August 2014. https://web.archive.org/web/20140801032832/http://www.wfsbp.org/fileadmin/user_upload/Treatment_Guidelines/Aigner_WFSBP_guidelines_eating_disorder_World_J_Biol_Psychia_11.pdf.
Cubeddu, Luigi X. (2016). «Drug-induced Inhibition and Trafficking Disruption of ion Channels: Pathogenesis of QT Abnormalities and Drug-induced Fatal Arrhythmias». Current Cardiology Reviews 12 (2): 141–154. doi:10.2174/1573403X12666160301120217. ISSN 1875-6557. PMID 26926294.
Tisdale, James E. (May 2016). «Drug-induced QT interval prolongation and torsades de pointes: Role of the pharmacist in risk assessment, prevention and management». Canadian Pharmacists Journal 149 (3): 139–152. doi:10.1177/1715163516641136. ISSN 1715-1635. PMID 27212965.
Gury, C.; Cousin, F. (September 1999). «[Pharmacokinetics of SSRI antidepressants: half-life and clinical applicability]». L'Encephale 25 (5): 470–476. ISSN 0013-7006. PMID 10598311.